Sanofi Has One Hemophilia Winner On It Hands – But Fitusiran’s Fate Remains Unclear

Efanesoctocog Alfa Filed Last Month

 
• By Andrew McConaghie
Sanofi_Berlin
Sanofi could be a major player in hemophilia within a few years - but will face competition from Roche's Hemlibra and gene therapies. • Source: Shutterstock

More from Blood and Clotting

More from Therapeutic Category